store at low temperature | store at -80°C
Guselkumab (CNTO 1959) 是一种针对IL-23p19亚基的重组人IgG1单克隆抗体。Guselkumab 与人和食蟹猴IL-23结合,Kd 值分别为3.3和1.9 pmol/L。Guselkumab 对IL-23信号通路下游细胞因子的产生具有抑制作用,可用于银屑病关节炎的研究。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 4,970 | 现货 | ||
5 mg | ¥ 9,870 | 现货 | ||
10 mg | ¥ 13,700 | 现货 | ||
25 mg | ¥ 19,800 | 现货 | ||
50 mg | ¥ 27,600 | 现货 | ||
100 mg | ¥ 37,200 | 现货 |
产品描述 | Guselkumab (CNTO 1959) is a recombinant human IgG1 monoclonal antibody targeting the IL-23p19 subunit. Guselkumab binds to human cynomolgus monkey IL-23 with Kd values of 3.3 and 1.9 pmol/L, respectively. Guselkumab can inhibit the production of cytokines downstream of IL-23 signaling pathway, and can be used in the study of psoriatic arthritis. |
靶点活性 | IL-23:0.06 nM (IC50), IL-23 (human):3.3 pM, IL-23 (monkey):1.9 pM, IL-23:0.06 pM(kd), STAT3 phosphorylation:102.1100±2.0053 nM |
体外活性 |
Guselkumab inhibits IL-23 (0.5 or 1 ng/mL)-mediated production of Th17 cytokines IL17A, IL-17F, and IL-22 in mouse splenocyteswith IC50 ranging 0.016-0.080 nM. And, it inhibits IL-23 (10 or 100 ng/mL)-mediated production of IL-10 in human NKL cells. Guselkumab has no effect on IL-12 (0.1 ng/mL)-mediated production of interferon γ (IFNγ) in NK92MI cells.[1] Guselkumab combines with IBI112 blocks IL-23-induced STAT3 phosphorylation, and Guselkumab blocks IL-23-induced STAT3 phosphorylation with an IC50 value of 102.1100±2.0053 nM.[2] Guselkumab blocks hIL-23-induced mIL-17 production in a dose-dependent manner, exhibiting an IC50 of 4.9743 ±1.2847 nM. In another experiment, Guselkumab also blocks IL-17F production in cynomolgus monkeys with an IC50 of 16.7950 nM.[2] |
别名 | CNTO 1959 |
分子量 | N/A |
分子式 | N/A |
CAS No. | 1350289-85-8 |
store at low temperature | store at -80°C
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Guselkumab 1350289-85-8 Immunology/Inflammation IL Receptor CNTO1959 CNTO 1959 CNTO-1959 Inhibitor inhibitor inhibit